In a double-blind trial of streptokinase for acute myocardial infarction, 219 consecutive patients presenting with infarction within four hours (mean, 3.0 +/- 0.8) of the onset of chest pain were randomly assigned to treatment with streptokinase (1.5 million units) or placebo, given intravenously over 30 minutes. The primary end point of the study was left ventricular function in patients with first infarctions. Patients who could undergo beta-blockade also received intravenous propranolol. Heparin (for 48 hours) and a combination of low-dose aspirin and dipyridamole were administered to both groups until cineangiography was performed at three weeks. In the patients with first infarctions treated with streptokinase, the left ventricular ejection fraction was 6 percentage points higher (streptokinase vs. placebo, 59 +/- 10.5 vs. 53 +/- 13.5 percent; P less than 0.005), with benefit to patients with either anterior infarction (57 +/- 11.9 vs. 49 +/- 15.9 percent; P less than 0.05) or inferior infarction (60 +/- 9.1 vs. 55 +/- 11.3 percent; P less than 0.05). Left ventricular function was improved regardless of whether concomitant propranolol was given. Survival (at 30 days) was improved with streptokinase: 2 deaths occurred among 79 patients who received this drug, as compared with 12 deaths among 93 patients who received placebo (2.5 vs. 12.9 percent, P = 0.012). Rates of reinfarction (streptokinase vs. placebo, 3 vs. 1 percent) and requirements for surgery or angioplasty (7 vs. 5 percent) were similar in the two groups. We conclude that administration of intravenous streptokinase (1.5 million units) to patients with a first myocardial infarction results in improved left ventricular function and short-term survival.
This article has been cited by other articles:
Marin, F., Gonzalez-Conejero, R., Capranzano, P., Bass, T. A., Roldan, V., Angiolillo, D. J.
(2009). Pharmacogenetics in cardiovascular antithrombotic therapy.. J Am Coll Cardiol
54: 1041-1057
[Abstract][Full Text]
Figueras, J., Alcalde, O., Barrabes, J. A., Serra, V., Alguersuari, J., Cortadellas, J., Lidon, R.-M.
(2008). Changes in Hospital Mortality Rates in 425 Patients With Acute ST-Elevation Myocardial Infarction and Cardiac Rupture Over a 30-Year Period. Circulation
118: 2783-2789
[Abstract][Full Text]
van der Schaaf, R J, Timmer, J R, Ottervanger, J P, Hoorntje, J C A, de Boer, M-J, Suryapranata, H, Zijlstra, F, Dambrink, J-H E
(2006). Long-term impact of multivessel disease on cause-specific mortality after ST elevation myocardial infarction treated with reperfusion therapy. Heart
92: 1760-1763
[Abstract][Full Text]
Gonzalez-Conejero, R., Fernandez-Cadenas, I., Iniesta, J. A., Marti-Fabregas, J., Obach, V., Alvarez-Sabin, J., Vicente, V., Corral, J., Montaner, J., for the Proyecto Ictus Research Group,
(2006). Role of Fibrinogen Levels and Factor XIII V34L Polymorphism in Thrombolytic Therapy in Stroke Patients. Stroke
37: 2288-2293
[Abstract][Full Text]
Marin, F., Gonzalez-Conejero, R., Lee, K. W., Corral, J., Roldan, V., Lopez, F., Sogorb, F., Caturla, J., Lip, G. Y.H., Vicente, V.
(2005). A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction. J Am Coll Cardiol
45: 25-29
[Abstract][Full Text]
de Kam, P. J, Voors, A. A, Fici, F., van Veldhuisen, D. J, van Gilst, W. H
(2004). Review: The revised role of ACE-inhibition after myocardial infarction in the thrombolytic/primary PCI era. Journal of Renin-Angiotensin-Aldosterone System
5: 161-168
[Abstract]
Blom, J.-R., van 't Hof, A. W.J., Henriques, J. P.S., Geertman, J. H., Slingerland, R., Hoorntje, J. C.A.
(2004). NT-proBNP: a marker for successful myocardial reperfusion in AMI patients treated with primary percutaneous coronary intervention. Eur J Heart Fail
6: 749-752
[Full Text]
Dixon, S. R., Whitbourn, R. J., Dae, M. W., Grube, E., Sherman, W., Schaer, G. L., Jenkins, J. S., Baim, D. S., Gibbons, R. J., Kuntz, R. E., Popma, J. J., Nguyen, T. T., O'Neill, W. W.
(2002). Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol
40: 1928-1934
[Abstract][Full Text]
Goldstein, J. A.
(2002). Pathophysiology and management of right heart ischemia. J Am Coll Cardiol
40: 841-853
[Abstract][Full Text]
de Kam, P.-J., Voors, A. A., Brouwer, J., St John Sutton, M., van Gilst, W. H.
(2002). Approaches to statistical analysis of repeated echocardiographic measurements after myocardial infarction and its relation to heart failure: Application of a random-effects model. Eur J Heart Fail
4: 277-282
[Abstract][Full Text]
Dixon, S. R., Bartorelli, A. L., Marcovitz, P. A., Spears, R., David, S., Grinberg, I., Qureshi, M. A., Pepi, M., Trabattoni, D., Fabbiocchi, F., Montorsi, P., O'Neill, W. W.
(2002). Initial experience with hyperoxemic reperfusion after primary angioplasty for acute myocardial infarction: Results of a pilot study utilizing intracoronary aqueous oxygen therapy. J Am Coll Cardiol
39: 387-392
[Abstract][Full Text]
Channer, K S, Pugh, P J
(2001). Interfering with healing: the benefits of intervention during acute myocardial infarction. Heart
85: 620-622
[Full Text]
Ohman, E. M., Harrington, R. A., Cannon, C. P., Agnelli, G., Cairns, J. A., Kennedy, J.W.
(2001). Intravenous Thrombolysis in Acute Myocardial Infarction. Chest
119
: 253S-277S
[Full Text]
de Kam, P. J., Voors, A. A., van den Berg, M. P., van Veldhuisen, D. J., Brouwer, J., Crijns, H. J. G. M., Borghi, C., Ambrosioni, E., Hochman, J. S., LeJemtel, T. H., Kingma, J.-H., St. John Sutton, M., van Gilst, W. H., on behalf of the FAMIS CAPTIN and CATS Investigato,
(2000). Effect of very early angiotensin-converting enzyme inhibition on left ventricular dilation after myocardial infarction in patients receiving thrombolysis: Results of a meta-analysis of 845 patients. J Am Coll Cardiol
36: 2047-2053
[Abstract][Full Text]
Morishima, I., Sone, T., Okumura, K., Tsuboi, H., Kondo, J., Mukawa, H., Matsui, H., Toki, Y., Ito, T., Hayakawa, T.
(2000). Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol
36: 1202-1209
[Abstract][Full Text]
Van de Water, N. S., French, J. K., Lund, M., Hyde, T. A., White, H. D., Browett, P. J.
(2000). Prevalence of factor v leiden and prothrombin variant g20210a in patients age <50 years with no significant stenoses at angiography three to four weeks after myocardial infarction. J Am Coll Cardiol
36: 717-722
[Abstract][Full Text]
French, J. K., Hyde, T. A., Straznicky, I. T., Andrews, J., Lund, M., Amos, D. J., Zambanini, A., Ellis, C. J., Webber, B. J., McLaughlin, S. C., Whitlock, R. M. L., Manda, S. O. M., Patel, H., White, H. D.
(2000). Relationship between corrected TIMI frame counts at three weeks and late survival after myocardial infarction. J Am Coll Cardiol
35: 1516-1524
[Abstract][Full Text]
Whan Lee, C., Park, S.-W., Cho, G.-Y., Hong, M.-K., Kim, J.-J., Kang, D.-H., Song, J.-K., Lee, H.-J., Park, S.-J.
(2000). Pressure-derived fractional collateral blood flow: a primary determinant of left ventricular recovery after reperfused acute myocardial infarction. J Am Coll Cardiol
35: 949-955
[Abstract][Full Text]
Harpaz, D., Behar, S., Gottlieb, S., Boyko, V., Kishon, Y., Eldar, M., for the SPRINT Study Group, , the Israeli Thrombolytic Survey Group,
(1999). Complete atrioventricular block complicating acute myocardial infarction in the thrombolytic era. J Am Coll Cardiol
34: 1721-1728
[Abstract][Full Text]
French, J. K., Hyde, T. A., Patel, H., Amos, D. J., McLaughlin, S. C., Webber, B. J., White, H. D.
(1999). Survival 12 years after randomization to streptokinase: the influence of thrombolysis in myocardial infarction flow at three to four weeks. J Am Coll Cardiol
34: 62-69
[Abstract][Full Text]
Kumar, A., Villani, M. P., Patel, U. K., Keith, J. C. Jr, Schaub, R. G.
(1999). Recombinant Soluble Form of PSGL-1 Accelerates Thrombolysis and Prevents Reocclusion in a Porcine Model. Circulation
99: 1363-1369
[Abstract][Full Text]
Gregorini, L., Marco, J., Kozakova, M., Palombo, C., Anguissola, G. B., Marco, I., Bernies, M., Cassagneau, B., Distante, A., Bossi, I. M., Fajadet, J., Heusch, G.
(1999). {alpha}-Adrenergic Blockade Improves Recovery of Myocardial Perfusion and Function After Coronary Stenting in Patients With Acute Myocardial Infarction. Circulation
99: 482-490
[Abstract][Full Text]
French, J. K., Amos, D. J., Williams, B. F., Cross, D. B., Elliott, J. M., Hart, H. H., Williams, M. G., Norris, R. M., Ashton, N. G., Whitlock, R. M. L., McLaughlin, S. C., White, H. D.
(1999). Effects of early captopril administration after thrombolysis on regional wall motion in relation to infarct artery blood flow. J Am Coll Cardiol
33: 139-145
[Abstract][Full Text]
Christenson, R. H., Azzazy, H. M. E.
(1998). Biochemical markers of the acute coronary syndromes. Clin. Chem.
44: 1855-1864
[Abstract][Full Text]
White, H. D., Van de Werf, F. J. J.
(1998). Thrombolysis for Acute Myocardial Infarction. Circulation
97: 1632-1646
[Abstract][Full Text]
Bowers, T. R., O'Neill, W. W., Grines, C., Pica, M. C., Safian, R. D., Goldstein, J. A.
(1998). Effect of Reperfusion on Biventricular Function and Survival after Right Ventricular Infarction. NEJM
338: 933-940
[Abstract][Full Text]
Wu, K. C., Zerhouni, E. A., Judd, R. M., Lugo-Olivieri, C. H., Barouch, L. A., Schulman, S. P., Blumenthal, R. S., Lima, J. A. C.
(1998). Prognostic Significance of Microvascular Obstruction by Magnetic Resonance Imaging in Patients With Acute Myocardial Infarction. Circulation
97: 765-772
[Abstract][Full Text]
White, R. L
(1998). Thrombolytic Therapy in Acute Myocardial Infarction Part II: 1997 Update. Asian Cardiovasc. Thorac. Ann.
6: 03-10
[Abstract][Full Text]
Genser, N., Lechleitner, P., Maier, J., Dienstl, F., Artner-Dworzak, E., Puschendorf, B., Mair, J.
(1998). Rebound increase of plasminogen activator inhibitor type 1 after cessation of thrombolytic treatment for acute myocardial infarction is independent of type of plasminogen activator used. Clin. Chem.
44: 209-214
[Abstract][Full Text]
White, H. D., Aylward, P. E., Frey, M. J., Adgey, A. A. J., Nair, R., Hillis, W. S., Shalev, Y., Brown, M. A., French, J. K., Collins, R., Maraganore, J., Adelman, B.
(1997). Randomized, Double-blind Comparison of Hirulog Versus Heparin in Patients Receiving Streptokinase and Aspirin for Acute Myocardial Infarction (HERO). Circulation
96: 2155-2161
[Abstract][Full Text]
Christenson, R. H., Ohman, E. M., Topol, E. J., Peck, S., Newby, L. K., Duh, S.-H., Kereiakes, D. J., Worley, S. J., Alosozana, G. L., Wall, T. C., Califf, R. M., 7 Study Group ;, R. M.
(1997). Assessment of Coronary Reperfusion After Thrombolysis With a Model Combining Myoglobin, Creatine Kinase–MB, and Clinical Variables. Circulation
96: 1776-1782
[Abstract][Full Text]
Melgarejo-Moreno, A., Galcera-Tomas, J., Garcia-Alberola, A., Valdes-Chavarri, M., Castillo-Soria, F. J., Mira-Sanchez, E., Gil-Sanchez, J., Allegue-Gallego, J.
(1997). Incidence, Clinical Characteristics, and Prognostic Significance of Right Bundle-Branch Block in Acute Myocardial Infarction : A Study in the Thrombolytic Era. Circulation
96: 1139-1144
[Abstract][Full Text]
Asanuma, T., Tanabe, K., Ochiai, K., Yoshitomi, H., Nakamura, K., Murakami, Y., Sano, K., Shimada, T., Murakami, R., Morioka, S., Beppu, S.
(1997). Relationship Between Progressive Microvascular Damage and Intramyocardial Hemorrhage in Patients With Reperfused Anterior Myocardial Infarction : Myocardial Contrast Echocardiographic Study. Circulation
96: 448-453
[Abstract][Full Text]
Nijland, F., Kamp, O., Verheugt, F. W.A., Veen, G., Visser, C. A.
(1997). Long-term Implications of Reocclusion on Left Ventricular Size and Function After Successful Thrombolysis for First Anterior Myocardial Infarction. Circulation
95: 111-117
[Abstract][Full Text]
Dakik, H. A., Mahmarian, J. J., Kimball, K. T., Koutelou, M. G., Medrano, R., Verani, M. S.
(1996). Prognostic Value of Exercise 201Tl Tomography in Patients Treated With Thrombolytic Therapy During Acute Myocardial Infarction. Circulation
94: 2735-2742
[Abstract][Full Text]
Haider, A. W., Andreotti, F., Thompson, G. R., Kluft, C., Maseri, A., Davies, G. J.
(1996). Serum Lipoprotein(a) Level Is Related to Thrombin Generation and Spontaneous Intermittent Coronary Occlusion in Patients With Acute Myocardial Infarction. Circulation
94: 2072-2076
[Abstract][Full Text]
French, J. K, Williams, B. F, Hart, H. H, Wyatt, S., Poole, J. E, Ingram, C., Ellis, C. J, Williams, M. G, White, H. D
(1996). Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction. BMJ
312: 1637-1641
[Abstract][Full Text]
Hussain, K.M.A., Gould, L., Sosler, B., Bharathan, T., Reddy, C.V.R.
(1996). Clinical Science Review: Current Aspects of Thrombolytic Therapy in Women with Acute Myocardial Infarction. ANGIOLOGY
47: 23-33
[Abstract]
Arstall, M. A., Yang, J., Stafford, I., Betts, W. H., Horowitz, J. D.
(1995). N-Acetylcysteine in Combination With Nitroglycerin and Streptokinase for the Treatment of Evolving Acute Myocardial Infarction : Safety and Biochemical Effects. Circulation
92: 2855-2862
[Abstract][Full Text]
Kellett, J., Clarke, J.
(1995). Comparison of "Accelerated" Tissue Plasminogen Activator with Streptokinase for Treatment of Suspected Myocardial Infarction. Med Decis Making
15: 297-310
[Abstract]
Terada, Y., Mitsui, T., Matsushita, S., Atsumi, N., Jikuya, T., Sakakibara, Y.
(1995). Influence of Bypass Grafting to the Infarct Artery on Late Potentials in Coronary Operations. Ann. Thorac. Surg.
60: 422-425
[Abstract][Full Text]
Ohnishi, Y., Butterfield, M. C., Saffitz, J. E., Sobel, B. E., Corr, P. B., Goldstein, J. A.
(1995). Deleterious Effects of a Systemic Lytic State on Reperfused Myocardium : Minimization of Reperfusion Injury and Enhanced Recovery of Myocardial Function by Direct Angioplasty. Circulation
92: 500-510
[Abstract][Full Text]
Lee, K. L., Woodlief, L. H., Topol, E. J., Weaver, W. D., Betriu, A., Col, J., Simoons, M., Aylward, P., Van de Werf, F., Califf, R. M.
(1995). Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction : Results From an International Trial of 41 021 Patients. Circulation
91: 1659-1668
[Abstract][Full Text]
Hundley, W. G., Clarke, G. D., Landau, C., Lange, R. A., Willard, J. E., Hillis, L. D., Peshock, R. M.
(1995). Noninvasive Determination of Infarct Artery Patency By Cine Magnetic Resonance Angiography. Circulation
91: 1347-1353
[Abstract][Full Text]
Ono, S., Waldman, L. K., Yamashita, H., Covell, J. W., Ross, J. Jr
(1995). Effect of Coronary Artery Reperfusion on Transmural Myocardial Remodeling in Dogs. Circulation
91: 1143-1153
[Abstract][Full Text]
Midgette, A. S., Wong, J. B., Beshansky, J. R., Porath, A., Fleming, C., Pauker, S. G.
(1994). Cost - Effectiueness of Streptokinase for Acute Myocardial Infarction: A Combined Meta-analysis and Decision Analysis of the Effects of Infarct Location and of Likelihood of Infarction. Med Decis Making
14: 108-117
[Abstract]
Anderson, H. V., Willerson, J. T.
(1993). Thrombolysis in Acute Myocardial Infarction. NEJM
329: 703-709
[Full Text]
(1992). Adult Advanced Cardiac Life Support. JAMA
268: 2199-2241
[Abstract]
Eckman, M. H., Wong, J. B., Salem, D. N., Pauker, S. G.
(1992). Direct Angioplasty for Acute Myocardial Infarction: A Review of Outcomes in Clinical Subsets. ANN INTERN MED
117: 667-676
[Abstract]
Lessler, D. S., Avins, A. L.
(1992). Cost, Uncertainty, and Doctors' Decisions: The Case of Thrombolytic Therapy. Arch Intern Med
152: 1665-1672
[Abstract]
Silber, H., Hausmann, M. J., Katz, A., Gilutz, H., Zucker, N., Ovsyshcher, I.
(1992). Short- and Long-Term Comparative Study of Anistreplase Versus Streptokinase in Acute Myocardial Infarction. ANGIOLOGY
43: 572-577
[Abstract]
Bovill, E. G., Terrin, M. L., Stump, D. C., Berke, A. D., Frederick, M., Collen, D., Feit, F., Gore, J. M., Hillis, L. D., Lambrew, C. T., Leiboff, R., Mann, K. G., Markis, J. E., Pratt, C. M., Sharkey, S. W., Sopko, G., Tracy, R. P., Chesebro, J. H.
(1991). Hemorrhagic Events during Therapy with Recombinant Tissue-Type Plasminogen Activator, Heparin, and Aspirin for Acute Myocardial Infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial. ANN INTERN MED
115: 256-265
[Abstract]
Popma, J. J., Topol, E. J.
(1991). Adjuncts to Thrombolysis for Myocardial Reperfusion. ANN INTERN MED
115: 34-44
[Abstract]
Sherry, S., Marder, V. J.
(1991). Streptokinase and Recombinant Tissue Plasminogen Activator (rt-PA) Are Equally Effective in Treating Acute Myocardial Infarction. ANN INTERN MED
114: 417-423
[Abstract]
Muller, D. W. M., Topol, E. J.
(1990). Selection of Patients with Acute Myocardial Infarction for Thrombolytic Therapy. ANN INTERN MED
113: 949-960
[Abstract]
Midgette, A. S., O'Connor, G. T., Baron, J. A., Bell, J.
(1990). Effect of Intravenous Streptokinase on Early Mortality in Patients with Suspected Acute Myocardial Infarction: A Meta-Analysis by Anatomic Location of Infarction. ANN INTERN MED
113: 961-968
[Abstract]
Naylor, C. D., Jaglal, S. B.
(1990). Impact of Intravenous Thrombolysis on Short-term Coronary Revascularization Rates: A Meta-analysis. JAMA
264: 697-702
[Abstract]
Collen, D.
(1990). Coronary Thrombolysis: Streptokinase or Recombinant Tissue-Type Plasminogen Activator?. ANN INTERN MED
112: 529-538
[Abstract]
Ovsyshcher, I., Silber, H., Hausman, M.I., Margolis, G., Gueron, M.
(1990). Improved Left Ventricular Function in Myocardial Infarction Following Intravenous Thrombolytic Therapy with Acylated Plasminogen Activator. ANGIOLOGY
41: 133-138
[Abstract]
Krichbaum, D. W., Trivedi, D. A.
(1990). Thrombolytic Therapy in Acute Myocardial Infarction. Journal of Pharmacy Practice
3: 332-348
Rowe, W. W., Simpson, R. J. Jr, Tate, D. A., Willis, P. W. IV, Nichols, T. C., Noneman, J. W., Gettes, L. S.
(1989). Nonemergent Cardiac Catheterization and Risk-Stratified Revascularization Following Thrombolytic Therapy for Acute Myocardial Infarction: A Critical Analysis of Therapy in the Community Setting. Arch Intern Med
149: 1611-1617
[Abstract]
Tate, D. A., Dehmer, G. J.
(1989). New Challenges for Thrombolytic Therapy. ANN INTERN MED
110: 953-955
[Abstract]
Haber, E, Quertermous, T, Matsueda, G., Runge, M.
(1989). Innovative approaches to plasminogen activator therapy. Science
243: 51-56
[Abstract]
Topol, E. J.
(1988). Coronary Angioplasty for Acute Myocardial Infarction. ANN INTERN MED
109: 970-980
[Abstract]
Kowey, P. R., Fisher, L., Giardina, E.-G., Leier, C. V., Lowenthal, D. T., Messerli, F. H., Pratt, C. M.
(1988). The TPA Controversy and the Drug Approval Process: The View of the Cardiovascular and Renal Drugs Advisory Committee. JAMA
260: 2250-2252
[Abstract]
Previous
